Shimura Masahiko; Kitano Shigehiko; Ogata Nahoko; Mitamura Yoshinori; Oh Hideyasu; Kollaborációs szervezet: YOSEMITE and RHINE Investigators; Bátor György; Seres András; Szalczer Lajos; Tóth-Molnár Edit; Vajas Attila; Varsány Balázs; Kerény Ágnes; Papp András; Szecskó Tímea; Vogt Gábor:
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1‑year results from the Japan subgroup of the phase 3 YOSEMITE trial.
JAPANESE JOURNAL OF OPHTHALMOLOGY, 67 (3).
pp. 264-279.
ISSN 0021-5155
(2023)
Jackson Timothy L.; Slakter Jason; Buyse Marc; Wang Kun; Dugel Pravin U.; Wykoff Charles C.; Boyer David S.; Gerometta Michael; Baldwin Megan E.; Price Clare F.; Kollaborációs szervezet: Opthea Study Group Investigator; Facskó Andrea; Kerényi Ágnes; Papp András; Vogt Gábor; et al.:
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration.
OPHTHALMOLOGY, 130 (6).
pp. 588-597.
ISSN 0161-6420
(2023)
Oddone Francesco; Kirwan James; Lopez-Lopez Fernando; Zimina Marina; Fassari Claudia; Holló Gábor; Kollaborációs szervezet: The VISIONARY Study Group; Németh Gábor; Ács Tamás; Ferencz Mária; Sohajda Zoltán; Tóth Jenő; Volner Veronika; Vogt Gábor; Facskó Andrea; et al.:
Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
ADVANCES IN THERAPY, 39 (8).
pp. 3501-3521.
ISSN 0741-238X
(2022)
Oddone Francesco; Tanga Lucia; Kóthy Péter; Holló Gábor; Kollaborációs szervezet: The VISIONARY Study Group; Németh Gábor; Bátor György; Ács Tamás; Ferencz Mária; Sohajda Zoltán; Tóth Jenő; Volner Veronika; Vogt Gábor; Facskó Andrea; Nemes János; et al.:
Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy : The VISIONARY Study.
ADVANCES IN THERAPY, 37 (4).
pp. 1436-1451.
ISSN 0741-238X
(2020)